Skip to main content
. 2010 Feb 16;28(9):1481–1488. doi: 10.1200/JCO.2009.24.1281

Table 2.

Incidence of Most Common (> 10%) Adverse Events of Abiraterone Acetate in Patients With Castration-Resistant Prostate Cancer

Adverse Event All Grades (N = 33)
Dose Cohort (No. of patients)
250 mg (n = 6)
500 mg (n = 9)
750 (n = 6)
1,000 mg (n = 12)
No. of Patients % Grade 1/2 Grade 3 Grade 1/2 Grade 3/4 Grade 1/2 Grade 3 Grade 1/2 Grade 3
Abdominal pain 6 18 1 2 2 1
Constipation 7 21 2 1 2 2
Diarrhea 10 30 3 2 1 4
Dry mouth 7 21 2 3 2
Dyspepsia 4 12 2 2
Nausea 11 33 1 3 1 6
Vomiting 5 15 1 1 3
Asthenia 8 24 1 3 2 2
Fatigue 22 67 3 7 4 8
Edema 5 15 1 3 1
Peripheral edema 8 24 2 6
Anorexia 7 21 1 2 1 3
Hyperglycemia 4 12 1 1 2
Hypokalemia 8 24 1 3 1 2 1
Arthralgia 5 15 1 2 1 1
Back pain 4 12 1 1 1 1
Muscular weakness 5 15 2 1 1 1
Dizziness 5 15 1 2 2
Headache 11 33 3 2 6
Cough 7 21 1 1 4 1
Hot flush 7 21 2 2 3
Hypertension 12 36 2 1 1 2 1 3 2
Hypotension 4 12 1 3